tiprankstipranks
Trending News
More News >
Kane Biotech Inc (TSE:KNE)
:KNE
Canadian Market

Kane Biotech (KNE) Income Statement

Compare
1 Followers

Kane Biotech Income Statement

Last quarter (Q3 2025), Kane Biotech's total revenue was C$8.50K, a decrease of -99.34% from the same quarter last year. In Q3, Kane Biotech's net income was C$-607.35K. See Kane Biotech’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
C$ 2.08MC$ 148.98KC$ 156.73KC$ 1.61MC$ 1.34M
Gross Profit
C$ 872.10KC$ 109.47KC$ 1.41MC$ 568.44KC$ 526.86K
Operating Expenses
C$ 4.80MC$ 3.47MC$ 4.78MC$ 5.45MC$ 4.75M
Depreciation and Amortization
C$ 218.47KC$ 116.05KC$ 257.68KC$ 187.97KC$ 78.11K
EBITDA
C$ -3.71MC$ -3.23MC$ -2.95MC$ -4.25MC$ -3.65M
Operating Income
C$ -4.49MC$ -3.36MC$ -3.46MC$ -4.88MC$ -4.22M
Other Income/Expenses
C$ 22.60KC$ -1.20MC$ -564.03KC$ 33.65KC$ 378.40K
Pretax Income
C$ -4.47MC$ -4.56MC$ -4.02MC$ -4.85MC$ -3.85M
Net Income
C$ -3.02MC$ -5.03MC$ -3.89MC$ -4.60MC$ -3.72M
Per Share Metrics
Basic EPS
C$ -0.02C$ -0.04C$ -0.03C$ -0.04C$ -0.03
Diluted EPS
C$ -0.02C$ -0.04C$ -0.03C$ -0.04C$ -0.03
Weighted Average Shares Outstanding
133.91M 140.26M 120.70M 112.60M 107.55M
Weighted Average Shares Outstanding (Diluted)
133.91M 127.12M 120.70M 112.60M 107.55M
Currency in CAD

Kane Biotech Earnings and Revenue History